PORTLAND, Ore. (KOIN) — A suspected hit-and-run driver believed to have caused two crashes was apprehended this week with the help of a new drone program in Washington County, authorities said.

VentureBeat made with Google Gemini 3.1 Pro Image Anthropic appears to have accidentally revealed the inner workings of one of its most popular and lucrative AI products, the agentic AI harness Claude ...

Web infrastructure giant Cloudlflare is seeking to transform the way enterprises deploy AI agents with the open beta release of Dynamic Workers, a new lightweight, isolate-based sandboxing system that ...

Claude code skills are an effective way to automate repetitive workflows, combining structured logic with adaptive AI-driven processes. As Jannis Moore explains, these skills are built around two core ...

EDMONDS, Wash. — Syreh Sonko is studying nursing at Edmonds College through Washington state's Running Start, but the program that's saving her nearly $30,000 in college costs may soon look different.

Luke Lindberg, USDA's undersecretary for trade and foreign agricultural affairs. (USDA photo) Luke Lindberg, USDA’s undersecretary for trade and foreign agricultural affairs, is the leading contender ...

Claude AI from Anthropic has been defining how AI advances for real use cases. Claude Code, an AI-coding and programming partner from Anthropic, is a great tool for writing code and fixing bugs. You ...

When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...

TURKU, Finland, Feb. 10, 2026 /PRNewswire/ -- Vaadin, the leading provider of Java web application frameworks, today announced the general availability of Swing Modernization Toolkit, a solution that ...

OpenAI just lobbed a grenade at vibe-coding startups like Cursor and Windsurf. The company behind ChatGPT has announced the Codex MacOS app, its take on an integrated development environment (IDE) ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.